Literature DB >> 3507214

An automated direct-injection HPLC-method for the electrochemical/fluorimetric quantitation of monoamines and related compounds optimized for the screening of large numbers of animals.

C A Seyfried1, G Adam, T Greve.   

Abstract

An automated, highly stable HPLC system is described allowing the quantitation of monoamines and related compounds with virtually online data processing and statistical evaluation of the mean values of various differently treated groups of animals. The system is highly suited to the screening of drugs involving large numbers of samples. To ensure long-term, uninterrupted performance, two robust chromatographic systems were developed optimized to separate neighboring peaks as widely as possible. This was achieved by using mobile phases of relatively low pH to retard acidic compounds, and optimal concentrations of the ion-pairing reagent to manipulate the retention times of amines on the RP-18 column, resulting also in clearcut separations from the solvent/tissue peak. Direct injection of deproteinized tissue samples, requiring no clean up procedures is used. One faster system allows measurement of the main biogenic amines, metabolites and TRP, whereas another system allows the simultaneous quantitation of DOPA, 5HTP, NA, MOPEG, NMN, A, MN, VMA, DA, 3MT, DOPAC, HVA, 5HT, 5HIAA and TYR. By pretreatment of animals with a decarboxylase inhibitor the latter system offers the possibility of detecting drug effects in the same animal on either dopamine and serotonin turnover or noradrenaline and serotonin turnover, depending on the brain area chosen. The system described has been running for over a year without major disturbance and with minimal technician attendance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3507214     DOI: 10.1002/bmc.1130010206

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  6 in total

1.  Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.

Authors:  Christoph van Amsterdam; Christoph A Seyfried
Journal:  Psychopharmacology (Berl)       Date:  2014-01-14       Impact factor: 4.530

2.  Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.

Authors:  A F Haase; H E Greiner; C A Seyfried
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

3.  Effect of acute swim stress on plasma corticosterone and brain monoamine levels in bidirectionally selected DxH recombinant inbred mouse strains differing in fear recall and extinction.

Authors:  Caroline A Browne; Joachim Hanke; Claudia Rose; Irene Walsh; Tara Foley; Gerard Clarke; Herbert Schwegler; John F Cryan; Deniz Yilmazer-Hanke
Journal:  Stress       Date:  2014-12       Impact factor: 3.493

4.  Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.

Authors:  A Barber; G D Bartoszyk; H E Greiner; F Mauler; R D Murray; C A Seyfried; M Simon; R Gottschlich; J Harting; I Lues
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

5.  A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

Authors:  A Barber; G D Bartoszyk; H M Bender; R Gottschlich; H E Greiner; J Harting; F Mauler; K O Minck; R D Murray; M Simon
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 6.  Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations.

Authors:  Jean-Benoît Corcuff; Laurence Chardon; Ines El Hajji Ridah; Julie Brossaud
Journal:  Endocr Connect       Date:  2017-05-31       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.